Cochlear Limited
ASX: COH
Stronger adult demand and emerging-market implant growth.
(Source: TradingView) 3-Month Performance Profile of COH on a DTF compared to S&P/ASX 200 (XJO).
Cochlear reported a solid FY25 underpinned by strong execution across its core implant franchise. Demand was particularly resilient among adult and senior patients, supported by intensified direct-to-consumer m
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
